Get the Stockscreener App
25.83
2.31%
-0.61
After Hours:
25.86
0.03
+0.12%
Overview
News
Price History
Option Chain
Financials
Why PFE Down?
Discussions
Forecast
Stock Split
Dividend History
Pfizer Inc Stock (PFE) Latest News
Is Pfizer Inc. (PFE) the Best Dividend Stock With 5% Yield? - Insider Monkey
Pfizer lures Novartis exec to be its chief oncology officer - The Pharma Letter
Huntsville biotech firm partnering with Pfizer lands $10 million for Parkinson’s trial - AL.com
Pfizer taps former Novartis exec to lead cancer drug push - BioPharma Dive
Pain Relief Medication Market Expected to Reach by 2031 | Pfizer - openPR
Injectable Drugs Market Is Booming Worldwide 2025-2032 | Pfizer Inc.. Cipla Inc., Sanofi S.A., GlaxoSmithKline - EIN News
Biosimilar Pipeline Analysis Market Detailed in New Research Report By 2032 | Biocon, Pfizer Inc, Merck & Co. - EIN News
Florida secures $2.3 million in settlement with Pfizer over Medicaid fraud allegations - Florida’s Voice
Car T Cell Therapy Market Projected To Witness Substantial Growth, 2025-2032 | Pfizer, bluebird bio, Johnson & - EIN News
Covid Products Drove Pfizer's Fourth Quarter. Is It Now A Buy? - Investor's Business Daily
Daiwa Securities Adjusts Price Target on Pfizer to $30 From $28, Keeps Outperform Rating - Marketscreener.com
Pfizer Inc. Reports Q4 2024 Earnings: EPS of $0.63 and Revenue o - GuruFocus.com
Respiratory Disease Vaccines Market Research Report 2025: Analysis and Forecast (2020-2030) Featuring GSK, Johnson & Johnson Services, Pfizer, Sanofi, Serum Institute of India, SINOVAC Biotech & More - GlobeNewswire Inc.
Pfizer to pay nearly $60M over kickbacks for migraine drug once promoted by Lady Gaga - AOL
Pfizer taps a former Novartis exec to lead cancer drug push - Yahoo Finance
Fast Melt Tablets Market Overall Study Report 2025-2032 | Pfizer - openPR
Attorney General's Office secures $2.3 million in multistate action from Pfizer-owned company - Florida Politics
Pfizer’s 2024 Earnings Call: Strong Performance and Strategic Growth - TipRanks
What's Going On With Pfizer Shares Wednesday? - Benzinga
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck - Yahoo Finance
PFIZER INC : Receives a Buy rating from DZ Bank -February 05, 2025 at 01:29 pm EST - Marketscreener.com
GSK, Pfizer sales of RSV shots slow as vaccination rates ebb - BioPharma Dive
UBS Adjusts Price Target on Pfizer to $28 From $29, Maintains Neutral Rating -February 05, 2025 at 10:02 am EST - Marketscreener.com
Pfizer Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Citigroup Adjusts Price Target on Pfizer to $27 From $29, Maintains Neutral Rating -February 05, 2025 at 06:36 am EST - Marketscreener.com
US-based drugmaker Pfizer reports Q4 2024 net income of $410m - World Pharmaceutical Frontiers
(02/05/25) Top Picks 2025: Pfizer (PFE) - Moneyshow.com
PFIZER INC : Gets a Neutral rating from JP Morgan -February 05, 2025 at 05:52 am EST - Marketscreener.com
Bank Hapoalim BM Sells 11,100 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer's CEO says he's had dinner with Trump's health secretary pick, RFK Jr. - Business Insider
Pfizer Inc (PFE) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - Yahoo Finance
Pfizer Reports Strong 2024 Financial Results - TipRanks
Pfizer shows profit growth from cost cuts and steadier COVID sales - MSN
Pfizer CEO had dinner with RFK Jr.: ‘I’m cautiously optimistic’ in spite of his history with vaccines - Fortune
Pfizer Back In The Deal Game In 2025 - Citeline News & Insights
Pfizer (NYSE:PFE) Trading Down 1.7%Here's What Happened - MarketBeat
Market movers: Spotify, Pfizer, Merck, Century Lithium... - Proactive financial news
RFK Jr. 'tempered' his stance on vaccines in private discussions, Pfizer CEO says - Yahoo Finance
Pfizer Q4 Earnings: Solid Results, But Guidance And Patent Concerns Drive Stock Down (PFE) - Seeking Alpha
Pfizer Earnings: After Solid Results, Reaffirmed 2025 Guidance - Morningstar
Pfizer Falls on RFK’s Progress Towards Confirmation Despite Good Earnings. Its CEO is Unbothered. - Barron's
Pfizer gets unexpected boost from Covid vaccine and pill - Fortune
Pfizer's CEO is 'cautiously optimistic' about RFK Jr. as Trump's health secretary - Yahoo Finance
Pfizer Shares Are Falling Today: What's Going On? - Benzinga
PFIZER INC : Receives a Buy rating from Jefferies -February 04, 2025 at 01:54 pm EST - Marketscreener.com
Unpacking the Latest Options Trading Trends in Pfizer - Benzinga
Pfizer's Q4 Earnings Beat Estimates, Non-Covid Drugs Drive Sales - MSN
Pfizer (PFE) Gets Unexpected Boost From Covid Vaccine and Pill - Bloomberg
Nessel, DOJ reach settlement with Pfizer subsidiary over kickback scheme - Yahoo News
Pfizer, Merck Q4 earnings: A break down of the pharma stocks - Yahoo Finance
AG Nessel secures $59.7M settlement from Pfizer subsidiary - WJMN
Pfizer tops Q4 sales and earnings expectations - Proactive Investors USA
Pfizer posts better-than-expected quarterly profit on cost cuts, steadier COVID-19 vaccine sales - The Globe and Mail
PFIZER INC : UBS reaffirms its Neutral rating -February 04, 2025 at 10:47 am EST - Marketscreener.com
Pfizer Shares Fall Despite EPS Soaring 530% in Q4 - Yahoo Finance
Pfizer Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Pfizer beats profit estimates on cost cuts, COVID vaccine sales -February 04, 2025 at 10:31 am EST - Marketscreener.com
Pfizer beats profit estimates on cost cuts, COVID vaccine sales - Yahoo Finance
100 Black Men of South Florida, Pfizer Partner to Raise Health Awareness - Miami's Community Newspapers
Pfizer Beats Expectations: Q4 and Full-Year 2024 Earnings ReportNews and Statistics - IndexBox, Inc.
Pfizer Shares Rise on Better-Than-Expected 4Q -February 04, 2025 at 09:59 am EST - Marketscreener.com
Pfizer Rises on Q4 Earnings Beat, 2025 Outlook Reaffirmed - Yahoo Finance
Pfizer beats Q4, FY '24 earnings estimates, stock flat in early trading - Yahoo Finance
Compared to Estimates, Pfizer (PFE) Q4 Earnings: A Look at Key Metrics - Yahoo Finance Australia
Pfizer Q4 Earnings: Revenue And EPS Beat, Seagen And COVID-19 Products Show Strength, Issues Strong FY25 Outlook - Yahoo Finance
Welch Group LLC Trims Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
3.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):